Twist Bioscience launched its HuTg model to expand antibody discovery services and complement existing in vivo platforms.
1 report, 1 independent
Updated Jul 31
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Twist Bioscience launched its HuTg model to expand antibody discovery services and complement existing in vivo platforms.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Coverage
Newest first; wire copies grouped- Business WireTwist Bioscience Expands In Vivo Antibody Discovery Services with Launch of Humanized Transgenic Mouse Model HuTg can be coupled with Twist hyperimmune DiversimAb mouse model and B cell screening met